Identify HCPs’ preferences and prescription trends for diabetes drugs

Diabetes is a chronic disease that affects millions of people worldwide. Healthcare professionals (HCPs) play a crucial role in managing diabetes by prescribing medications that help control blood sugar levels. To ensure that patients receive the best possible care, it is important to understand the preferences and prescription trends of HCPs when it comes to diabetes drugs.

A study was conducted to identify the preferences of HCPs and their current prescription trends in terms of drug classes and molecules in diabetic patients. The study found that HCPs tend to prescribe metformin as the first-line therapy for diabetes, followed by sulfonylureas and dipeptidyl peptidase-4 inhibitors. The study also revealed that HCPs prefer to prescribe drugs that have a low risk of hypoglycemia and are cost-effective. By understanding the prescription trends and preferences of HCPs, healthcare organizations can develop strategies to improve patient outcomes and ensure that patients receive the best possible care for their diabetes.